A group of plaintiffs who have filed Viagra skin cancer lawsuits in federal courts are requesting that all pending federal Viagra lawsuits be centralized in a multidistrict litigation. In a December transfer motion, the plaintiffs argued that the Viagra lawsuits in question “assert virtually identical claims against the same Defendant, for the same injury, caused by the same drug.”
Viagra is a phosphodiesterase type 5 (PDE5) inhibitor manufactured by ...
continue reading...